MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1210/clinem/dgag271

Медицинская библиотека · The Journal of clinical endocrinology and metabolism · 2026

Reduced Breast Cancer Risk in Women With A History of Pre-Eclampsia: Implications of Postmenopausal Hormone Therapy.

Joensuu Johanna M, Ylikorkala Olavi, Siitonen Heli, Savolainen-Peltonen Hanna, Mikkola Tomi S

СтатьяПеревод в очереди

Аннотация

CONTEXT: Both prior pre-eclamptic pregnancy and menopausal hormone therapy (MHT) are determinants for breast cancer (BC).

OBJECTIVE

To study the effects of prior pre-eclampsia and MHT use on BC risk.

DESIGN

Register-based cohort study with follow-up for BC (Finnish Cancer Register 1987-2023) and MHT use (National Reimbursement Register 1994-2019).

SETTING

Nationwide population-based study in Finland.

PARTICIPANTS

Women with prior pre-eclampsia (n = 31 688) and age-matched control women without pre-eclampsia (n = 91 726) who had given birth in 1969-1993.

INTERVENTION: The BC risks were compared between prior pre-eclamptic and control women and between prior pre-eclamptic MHT users and non-users.

RESULTS

Breast cancer occurred less frequently (p = 0.02) in prior pre-eclamptic women (6.6%, n = 2095) than in the controls (7.0%, n = 6410). The age-adjusted BC risk in prior pre-eclamptic women (aHR=0.89, 95% CI 0.83-0.94) was reduced. No clinical characteristics from pre-eclamptic pregnancy (e.g. severity) predicted the magnitude of the BC risk reduction.MHT use was accompanied with comparable BC risk rise in prior pre-eclamptic and control women (1.25, 1.12-1.40 vs. 1.30, 1.18-1.42). The increased risk with any MHT use was seen in both cohorts already after 5 years. This was primarily associated to estrogen-progestogen use, whereas estrogen only was not associated with BC risk in prior pre-eclamptic women.

CONCLUSIONS

BC risk is reduced in women with a history of pre-eclampsia. The MHT-associated increase in BC risk is similar among women with or without a history of pre-eclampsia. Thus, pre-eclampsia is no contraindication for the use of MHT.

Для цитирования: Joensuu Johanna M, Ylikorkala Olavi, Siitonen Heli, Savolainen-Peltonen Hanna, Mikkola Tomi S. Reduced Breast Cancer Risk in Women With A History of Pre-Eclampsia: Implications of Postmenopausal Hormone Therapy.. The Journal of clinical endocrinology and metabolism. 2026. DOI: 10.1210/clinem/dgag271.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.